Skip to main content

Alice Goodman

Feature
01/17/2011
A study presented at the AHA meeting suggests that patent foramen ovale closure using the STARFlex septal repair implantable device is of no benefit in preventing recurrent stroke for the vast majority of patients who have sustained a...
A study presented at the AHA meeting suggests that patent foramen ovale closure using the STARFlex septal repair implantable device is of no benefit in preventing recurrent stroke for the vast majority of patients who have sustained a...
A study presented at the AHA...
01/17/2011
First Report Managed Care
Feature
01/17/2011
Chicago—Eplerenone added to standard therapy for heart failure (HF) significantly reduced the risk of cardiovascular death or HF in patients with mild HF versus placebo. These findings of the EMPHASIS-HF (Eplerenone in Mild Patients...
Chicago—Eplerenone added to standard therapy for heart failure (HF) significantly reduced the risk of cardiovascular death or HF in patients with mild HF versus placebo. These findings of the EMPHASIS-HF (Eplerenone in Mild Patients...
Chicago—Eplerenone added to...
01/17/2011
First Report Managed Care
Feature
01/17/2011
Chicago—Warfarin is used only in a minority of elderly patients after bioprosthetic aortic valve replacement (BVR) surgery, despite the fact that this procedure carries an early risk of thromboembolic events. Elderly patients undergoing BVR...
Chicago—Warfarin is used only in a minority of elderly patients after bioprosthetic aortic valve replacement (BVR) surgery, despite the fact that this procedure carries an early risk of thromboembolic events. Elderly patients undergoing BVR...
Chicago—Warfarin is used only in...
01/17/2011
First Report Managed Care
Feature
01/17/2011
Chicago—Rivaroxaban, an investigational antithrombotic drug, was found to be at least as effective as warfarin in patients with paroxysmal atrial fibrillation (AF), with fewer dangerous side effects, such as intracranial hemorrhage and fatal...
Chicago—Rivaroxaban, an investigational antithrombotic drug, was found to be at least as effective as warfarin in patients with paroxysmal atrial fibrillation (AF), with fewer dangerous side effects, such as intracranial hemorrhage and fatal...
Chicago—Rivaroxaban, an...
01/17/2011
First Report Managed Care
01/17/2011
Research suggests that the risk of stroke is elevated in women who have more—not less—sleep. Women who slept ≥10 hours per night had a 63% increased risk of stroke compared with those who slept <7 hours per night in a substudy of the...
Research suggests that the risk of stroke is elevated in women who have more—not less—sleep. Women who slept ≥10 hours per night had a 63% increased risk of stroke compared with those who slept <7 hours per night in a substudy of the...
Research suggests that the risk...
01/17/2011
First Report Managed Care
Feature
01/17/2011
Chicago—Drug-eluting stents (sirolimus-eluting and everolimus-eluting) were found as safe as a baremetal stent in large arteries of patients with coronary heart disease in the BASKET-PROVE (Basel Stent Kosten-Effektivitäts Trial Prospective...
Chicago—Drug-eluting stents (sirolimus-eluting and everolimus-eluting) were found as safe as a baremetal stent in large arteries of patients with coronary heart disease in the BASKET-PROVE (Basel Stent Kosten-Effektivitäts Trial Prospective...
Chicago—Drug-eluting stents...
01/17/2011
First Report Managed Care